Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894823184> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2894823184 endingPage "1310" @default.
- W2894823184 startingPage "1306" @default.
- W2894823184 abstract "There is a rising prevalence of hepatitis C (HCV) among women of child-bearing age nationally, which prompted a recommendation by national guidelines to screen all women for HCV during pregnancy. Women with HCV during pregnancy are at risk of perinatal transmission of HCV. Directly acting antiviral (DAA) therapy during pregnancy can potentially reduce the risk of perinatal transmission as well as cure women while they are engaged in antenatal care. However, data on the safety and efficacy of DAAs during pregnancy are limited. We aimed to evaluate the preferences of women with HCV regarding potential DAA treatment during pregnancy. We conducted a survey of women with a history of HCV followed in the University of California, San Francisco HCV clinic and in the Women’s Interagency HIV Study (most of whom are coinfected with HIV) to determine their preferences for DAA treatment during pregnancy. A total of 141 women completed the survey. Sixty percent reported that they would be willing to take antepartum DAA therapy if it lowered the risk of perinatal transmission. Only 21% reported that they would agree to take DAA therapy during pregnancy for self-cure; 20% of women stated that they would not, yet indicated that they might change their minds if there were more human data available regarding use of DAAs during pregnancy. In multivariable analysis, having a previous history of taking DAAs and being of childbearing age at the time of the survey were associated with willingness to take DAA medication during pregnancy (odds ratios 4.29 and 4.11, respectively). Conclusion: These results point to the need for further investigation of the role of HCV therapy during pregnancy. As a result of the increasing rate of HCV among women of child-bearing age, the AASLD/IDSA HCV guidelines recently recommended universal HCV screening during pregnancy. Although direct acting antiviral agents are pregnancy category B, their safety and efficacy during pregnancy has not been evaluated. We therefore conducted a survey of women with HCV regarding their views on potential DAA treatment during pregnancy in order to determine whether there is a role for further investigation of DAA use during pregnancy. We found that despite limited safety/efficacy data, more than half of women with HCV would consider taking DAAs during pregnancy to prevent mother-to-child transmission of HCV." @default.
- W2894823184 created "2018-10-12" @default.
- W2894823184 creator A5001672217 @default.
- W2894823184 creator A5002438645 @default.
- W2894823184 creator A5019470247 @default.
- W2894823184 creator A5070182181 @default.
- W2894823184 date "2018-11-01" @default.
- W2894823184 modified "2023-10-12" @default.
- W2894823184 title "Evaluating Women’s Preferences for Hepatitis C Treatment During Pregnancy" @default.
- W2894823184 cites W1766750158 @default.
- W2894823184 cites W2024197225 @default.
- W2894823184 cites W2612307902 @default.
- W2894823184 cites W2799382774 @default.
- W2894823184 doi "https://doi.org/10.1002/hep4.1264" @default.
- W2894823184 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6211328" @default.
- W2894823184 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30411077" @default.
- W2894823184 hasPublicationYear "2018" @default.
- W2894823184 type Work @default.
- W2894823184 sameAs 2894823184 @default.
- W2894823184 citedByCount "27" @default.
- W2894823184 countsByYear W28948231842018 @default.
- W2894823184 countsByYear W28948231842019 @default.
- W2894823184 countsByYear W28948231842020 @default.
- W2894823184 countsByYear W28948231842021 @default.
- W2894823184 countsByYear W28948231842022 @default.
- W2894823184 countsByYear W28948231842023 @default.
- W2894823184 crossrefType "journal-article" @default.
- W2894823184 hasAuthorship W2894823184A5001672217 @default.
- W2894823184 hasAuthorship W2894823184A5002438645 @default.
- W2894823184 hasAuthorship W2894823184A5019470247 @default.
- W2894823184 hasAuthorship W2894823184A5070182181 @default.
- W2894823184 hasBestOaLocation W28948231841 @default.
- W2894823184 hasConcept C119599485 @default.
- W2894823184 hasConcept C126322002 @default.
- W2894823184 hasConcept C127413603 @default.
- W2894823184 hasConcept C131872663 @default.
- W2894823184 hasConcept C156957248 @default.
- W2894823184 hasConcept C203014093 @default.
- W2894823184 hasConcept C2776455275 @default.
- W2894823184 hasConcept C2779234561 @default.
- W2894823184 hasConcept C512399662 @default.
- W2894823184 hasConcept C54355233 @default.
- W2894823184 hasConcept C71924100 @default.
- W2894823184 hasConcept C761482 @default.
- W2894823184 hasConcept C86803240 @default.
- W2894823184 hasConceptScore W2894823184C119599485 @default.
- W2894823184 hasConceptScore W2894823184C126322002 @default.
- W2894823184 hasConceptScore W2894823184C127413603 @default.
- W2894823184 hasConceptScore W2894823184C131872663 @default.
- W2894823184 hasConceptScore W2894823184C156957248 @default.
- W2894823184 hasConceptScore W2894823184C203014093 @default.
- W2894823184 hasConceptScore W2894823184C2776455275 @default.
- W2894823184 hasConceptScore W2894823184C2779234561 @default.
- W2894823184 hasConceptScore W2894823184C512399662 @default.
- W2894823184 hasConceptScore W2894823184C54355233 @default.
- W2894823184 hasConceptScore W2894823184C71924100 @default.
- W2894823184 hasConceptScore W2894823184C761482 @default.
- W2894823184 hasConceptScore W2894823184C86803240 @default.
- W2894823184 hasIssue "11" @default.
- W2894823184 hasLocation W28948231841 @default.
- W2894823184 hasLocation W28948231842 @default.
- W2894823184 hasLocation W28948231843 @default.
- W2894823184 hasLocation W28948231844 @default.
- W2894823184 hasLocation W28948231845 @default.
- W2894823184 hasLocation W28948231846 @default.
- W2894823184 hasOpenAccess W2894823184 @default.
- W2894823184 hasPrimaryLocation W28948231841 @default.
- W2894823184 hasRelatedWork W1972756683 @default.
- W2894823184 hasRelatedWork W2024008300 @default.
- W2894823184 hasRelatedWork W2109994796 @default.
- W2894823184 hasRelatedWork W2352507830 @default.
- W2894823184 hasRelatedWork W2401739700 @default.
- W2894823184 hasRelatedWork W2793008352 @default.
- W2894823184 hasRelatedWork W2798199048 @default.
- W2894823184 hasRelatedWork W3009186173 @default.
- W2894823184 hasRelatedWork W3046001131 @default.
- W2894823184 hasRelatedWork W3114540110 @default.
- W2894823184 hasVolume "2" @default.
- W2894823184 isParatext "false" @default.
- W2894823184 isRetracted "false" @default.
- W2894823184 magId "2894823184" @default.
- W2894823184 workType "article" @default.